Showing results (441-450 of 484) with videos related to
Sort By:
Pageof 49
Translational Lung Cancer Research|August 12, 2022
Efficacy and safety of first-line anlotinib-based combinations for advanced non-small cell lung cancer: a three-armed prospective studyTianqing Chu, Wei Zhang, Bo Zhang, et al.JCO Precision Oncology|September 7, 2023
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)Riha Vaidya, Joseph M Unger, Lu Qian, et al.Nature Biotechnology|March 29, 2016
Integrated digital error suppression for improved detection of circulating tumor DNAAaron M Newman, Alexander F Lovejoy, Daniel M Klass, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP StudyPhilip C Mack, Mary W Redman, Hanna Tukachinsky, et al.Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancerDavid E Gerber, Mark A Socinski, Joel W Neal, et al.Cancer Discovery|February 26, 2021
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II TrialGregory J Riely, Joel W Neal, D Ross Camidge, et al.JAMA Oncology|October 26, 2023
Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the USEunji Choi, Victoria Y Ding, Sophia J Luo, et al.Cancer|October 25, 2023
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction modelEunji Choi, Sophia J Luo, Victoria Y Ding, et al.Journal for Immunotherapy of Cancer|May 31, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesotheliomaRamaswamy Govindan, Charu Aggarwal, Scott J Antonia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2018
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical OutcomesNicolas Marcoux, Scott N Gettinger, Grainne O'Kane, et al.Pageof 49